Tech Company Financing Transactions
E25Bio Funding Round
E25Bio closed a $2 million funding round on 3/19/2020. Backers included Khosla Ventures.
Transaction Overview
Company Name
Announced On
3/19/2020
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The new funding will go towards research and development, clinical studies, and scaling the company's launch for diagnostic tests upon receiving EUA approval.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
501 Massachusetts Ave.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Undisclosed
Website
Email Address
Overview
Founded in 2018 based on technology developed by Drs. Irene Bosch and Lee Gehrke and licensed from MIT, E25Bio is developing rapid diagnostic test technology for at-home-use that can detect dangerous infectious diseases -- such as the acute febrile illnesses that affect more than 700 million people each year -- in minutes instead of days.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bobby Herrera
Chief Operating Officer
Enrique Shadah
Chief Technical Officer
Irene Bosch
Co-Founder
Lee Gehrke
Browse more venture capital transactions:
Prev: 3/19/2020: Novi Connect venture capital transaction
Next: 3/19/2020: Around venture capital transaction
Share this article
Where The Data Comes From
We document funding rounds that are announced publicly. VC investment data records reported here are derived from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs